Login/Sign Up
MRP ₹106250
(Inclusive of all Taxes)
₹10625.0 Cashback (10%)
Provide Delivery Location
Online payment accepted
Whats That
About Erbitux 5 mg/ml Injection
Erbitux 5 mg/ml Injection belongs to a class of monoclonal antibodies. It is used with or without radiation therapy to treat various cancer conditions, such as metastatic cancer of the large intestine and squamous cell cancer (a certain type of head and neck cancer). Cancer is a genetic change in which the body's cells divide uncontrollably and spread into surrounding tissues.
Erbitux 5 mg/ml Injection contains Cetuximab, which works by slowing or stopping the growth of cancer cells. As a result, it prevents the cancer from spreading.
Erbitux 5 mg/ml Injection will be administered by a qualified healthcare professional who is experienced in the administration of chemotherapeutic agents. The most common side effects are inflammation of the lining of the intestine, mouth, and nose, nose bleeding, headache, tiredness, irritation and redness of the eye, diarrhoea, feeling sick, vomiting, loss of appetite, and weight loss. Talk to your doctor if any of these side effects persist or worsen.
It is recommended not to use if you are allergic to any ingredient in Erbitux 5 mg/ml Injection . Erbitux 5 mg/ml Injection may cause foetal harm when administered to a pregnant woman. It is critical not to become pregnant while undergoing therapy and for several months after the treatment. Before beginning treatment, discuss effective contraception with your healthcare professional. Inform them immediately if you or your partner becomes pregnant while undergoing therapy. Do not breastfeed your baby while on treatment with Cetuximab and for two months after the last dose. Alcohol should be avoided during treatment with this medicine. Drive only if you are alert, as the Erbitux 5 mg/ml Injection may cause you to feel sick or tired.
If you have head and neck cancer and are treated with radiation therapy with cetuximab, you may be at an elevated risk of cardiopulmonary arrest (when the heart stops beating and respiration stops) and sudden death during or after treatment. Inform your doctor if you have or have ever had coronary artery disease (a condition in which the blood vessels of the heart narrow or become clogged by fat or cholesterol deposits); heart failure (a condition in which the heart is unable to pump enough blood to the rest of the body); irregular heartbeat; other heart disease; or lower than normal levels of magnesium, potassium, or calcium in your blood.
Uses of Erbitux 5 mg/ml Injection
Directions for Use
Medicinal Benefits
Erbitux 5 mg/ml Injection is a monoclonal antibody. It is used alone or in combination with other anticancer medications to treat various cancer diseases, including metastatic cancer of the large intestine and squamous cell cancer (a form of head and neck cancer). Cetuximab is present in Erbitux 5 mg/ml Injection and works by slowing or preventing the growth of cancer cells. As a result, it inhibits the cancer from spreading.
Storage
Drug Warnings
Before taking Erbitux 5 mg/ml Injection , inform your doctor about your medical history and ongoing therapies to rule out potential adverse effects or interactions. It's crucial to take your medication as directed. The dosage of this medicine is based on your condition. Your doctor may adjust your dose during therapy based on the treatment results. Consult a doctor immediately if you suffer any symptoms, especially if you also have a cough or fever, such as the onset or worsening of breathing problems. If therapy needs to be stopped, your doctor will make that decision. Erbitux 5 mg/ml Injection is recommended not to be used in pregnant women or nursing mothers; if you become pregnant while on treatment with Cetuximab, tell your doctor right away.
Diet & Lifestyle Advise
Side Effects of Erbitux 5 mg/ml Injection
Habit Forming
Therapeutic Class
Product Substitutes
We provide you with authentic, trustworthy and relevant information
Erbitux 5 mg/ml Injection contains Cetuximab, which works by slowing or stopping the growth of cancer cells. Thereby, it prevents the cancer from spreading.
Attend all your doctor's appointments while taking Erbitux 5 mg/ml Injection to ensure the therapy is effective. Regular blood tests and weight checks must be performed. While taking the Erbitux 5 mg/ml Injection , both men and women should use an effective means of contraception. Do not use any other medications unless prescribed by the doctor. If you have low levels of Magnesium and Calcium in your blood, inform your doctor before treating you with this medicine.
Do not stop taking Erbitux 5 mg/ml Injection on your own. Take Erbitux 5 mg/ml Injection for as long as your doctor prescribes it, depending on your medical condition. Do not miss any scheduled dose. Speak with your doctor if you experience difficulty using Erbitux 5 mg/ml Injection .
Some dietary changes can help you manage side effects; for example, in case of diarrhoea-Choose foods or drinks with sodium (sports drinks or broth) and potassium (bananas and all-natural fruit juices).
Drug-Drug Interactions Checker List
Special Advise
Do not skip any scheduled doctor or lab appointments.
Disease/Condition Glossary
Cancer: Cancer is a genetic change in which the body's cells divide uncontrollably and spread into surrounding tissues. There are two types of cancer: benign (localized) and metastatic (spread to the whole body). Types of cancer include blood, lung, breast, etc. Cancer growth can be prevented by chemotherapy, radiation, and stem cell therapy.
Metastatic cancer: Metastasis occurs when cancer cells move from the colon to other organs. This is also known as stage IV colon cancer or advanced colon cancer.
Head and Neck Cancer: Cancers of the larynx, throat, lips, mouth, nose, and salivary glands are among the head and neck cancers. Human papillomavirus (HPV) infection, excessive alcohol consumption, and tobacco use all raise the risk of head and neck cancer.
Have a query?
Buy best Neoplastic Disorders products by
Intas Pharmaceuticals Ltd
Natco Pharma Ltd
Dr Reddy's Laboratories Ltd
Cipla Ltd
Celon Laboratories Pvt Ltd
Sun Pharmaceutical Industries Ltd
Alkem Laboratories Ltd
United Biotech Pvt Ltd
Zydus Cadila
Zydus Healthcare Ltd
Neon Laboratories Ltd
Glenmark Pharmaceuticals Ltd
Mylan Pharmaceuticals Pvt Ltd
BDR Pharmaceuticals Internationals Pvt Ltd
Emcure Pharmaceuticals Ltd
Adley Formulations
Samarth Life Sciences Pvt Ltd
Hetero Drugs Ltd
Torrent Pharmaceuticals Ltd
Fresenius Kabi India Pvt Ltd
Pfizer Ltd
Admac Lifesciences(Oncology)
Adley Pharmaceuticals Ltd
Novartis India Ltd
Halsted Pharma Pvt Ltd
Getwell Life Sciences India Pvt Ltd
Lupin Ltd
Cadila Healthcare Ltd
Hetero Healthcare Pvt Ltd
GLS Pharma Ltd
Reliance Formulation Pvt Ltd
Abbott India Ltd
Aimcad Biotech Pvt Ltd
Astra Zeneca Pharma India Ltd
Therdose Pharma Pvt Ltd
Axiommax Oncology Pvt Ltd
Biochem Pharmaceutical Industries Ltd
Khandelwal Laboratories Pvt Ltd
Msn Laboratories Pvt Ltd
Aureate Healthcare
Caitlin Oncology
Dabur India Ltd
Zee Laboratories Ltd
Sarabhai Chemicals (India) Pvt Ltd
Wembrace Biopharma Pvt Ltd
Delarc Pharmaceuticals Pvt Ltd
Medaegis Biotek Pvt Ltd
Panacea Biotec Ltd
RPG Life Sciences Ltd
Shilpa Medicare Ltd
Getwell Oncology Pvt Ltd
Ipca Laboratories Ltd
Miracalus Pharma Pvt Ltd
Biocon Ltd
Cadila Pharmaceuticals Ltd
Eli Lilly and Company (India) Pvt Ltd
Ferring Pharmaceuticals Pvt Ltd
Fresenius Kabi Oncology Ltd
Getwell Pharmaceutical Pvt Ltd
Maximal Healthcare Pvt Ltd
Boehringer Ingelheim India Pvt Ltd
Del Trade International Pvt Ltd
Sayre Therapeutics Pvt Ltd
Akumentis Healthcare Ltd
Corona Remedies Pvt Ltd
Eisai Pharmaceuticals India Pvt Ltd
GlaxoSmithKline Pharmaceuticals Ltd
Hilfen Pharmaceuticals Pvt Ltd
Johnson & Johnson Pvt Ltd
Mankind Pharma Pvt Ltd
Merck Ltd
Oncostar Pharma Pvt Ltd
Rhone Poulenc Rorer India Pvt Ltd
Vhb Life Sciences Inc
Zuventus Healthcare Ltd
Admac Pharma Ltd
Adonis Laboratories Pvt Ltd
Alniche Life Sciences Pvt Ltd
BPRL Pvt Ltd
Caitlin Life Care
Dr Care
German Remedies Ltd
Janssen Pharmaceuticals Pvt Ltd
MEDICAMEN BIOTECH LTD
Maxis Healthcare (I) Pvt Ltd
Pharm Products Pvt Ltd
Accord Life Spec Pvt Ltd
Amps Biotech Biotech Pvt Ltd
Aphia Healthcare
Astellas Pharma India Pvt Ltd
Bangalore Pharmaceutical and Research Laboratory Pvt Ltd (BPRL)
Bharat Serums and Vaccines Ltd
Cellgen Biopharma
Cosmic Life Sciences
Daris Biocare
East West Pharma India Pvt Ltd
Hillrock Biotech Pvt Ltd
Lucien Life Sciences
Maneesh Pharmaceuticals Ltd
Medilief Bioscience Pvt Ltd
Alcohol
Unsafe
Avoid alcohol consumption while on treatment with Erbitux 5 mg/ml Injection as it may cause serious side effects.
Pregnancy
Unsafe
Erbitux 5 mg/ml Injection is not recommended for use during pregnancy. So, inform your doctor if you are pregnant or suspect pregnancy. You or your partner must use a reliable form of contraception to prevent pregnancy while on treatment with Erbitux 5 mg/ml Injection .
Breast Feeding
Unsafe
Do not breastfeed your baby when you are being treated with Erbitux 5 mg/ml Injection and for two months after the last dose.
Driving
Caution
Drive only if alert, as the Erbitux 5 mg/ml Injection may cause feeling sick or tiredness.
Liver
Caution
If you have a pre-existing or a history of liver disease, inform your doctor before receiving Erbitux 5 mg/ml Injection . Your doctor will weigh the benefits and potential risks before prescribing this medicine.
Kidney
Caution
If you have a pre-existing or a history of kidney disease, inform your doctor before taking Erbitux 5 mg/ml Injection . Your doctor may titrate the dose if required based on your condition.
Children
Safe if prescribed
Erbitux 5 mg/ml Injection can be used to treat certain cancers in children. Please consult your doctor for more information.